H19 and cancer: As shown in Fig. 1A, the expression levels of H19 were lower in EBV-positive compared with EBV-negative cancer cells; however, the expression of H19 was significantly upregulated after treatment with 5-Aza-CdR in EBV-positive cancer cells (Fig. 2C).